4//SEC Filing
Tourangeau Greg 4
Accession 0000899243-22-026322
CIK 0001680581other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:15 PM ET
Size
10.0 KB
Accession
0000899243-22-026322
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2022-07-15+16,540→ 16,540 totalExercise: $5.39Exp: 2032-07-14→ Common Stock (16,540 underlying)
Footnotes (1)
- [F1]This option was granted on July 15, 2022 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2022, subject to the reporting person's continued service on each such vesting date.
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001916566
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:15 PM ET
- Size
- 10.0 KB